Survival statistics for non-Hodgkin lymphoma

Last medical review:

Survival statistics for non-Hodgkin lymphoma (NHL) are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.

There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for NHL and what they mean to you.

Survival varies with each stage and particular type of NHL. There are more than 60 different types of NHL and each behaves and responds to treatment differently. Doctors will consider each type’s individual behaviour, prognostic factors and expected response to treatment before they make a prognosis.

Net survival

Net survival represents the probability (chance) of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive cancer.

In Canada, the 5-year net survival for NHL is 69%. This means that, on average, about 69% of people diagnosed with NHL will survive for at least 5 years.

Survival by stage and type of NHL

Survival varies with each stage, type of NHL and the number of poor prognostic factors defined by the International Prognostic Index (IPI) and other indexes available for certain types of NHL. Generally, the earlier NHL is diagnosed and treated, the better the outcome. NHL often responds well to the many effective treatments that are available.

There are no specific Canadian statistics available for the different stages or types of NHL. The following information comes from a variety of sources. It may include statistics from other countries that are likely to have similar outcomes as in Canada.

All types of NHL combined
Stage 5-year relative survival
1 84%
2 and 3 71% to 77%
4 64%

All stages combined
Type of NHL 5-year relative survival
Follicular lymphoma 90%
Mycosis fungoides 90%
Marginal zone lymphomas* 80%
Diffuse large B-cell lymphoma (DLBCL) 60%
Burkitt lymphoma 55%
Sezary syndrome 45%
Mantle cell lymphoma 40%
Peripheral T-cell lymphoma (all types) 35%
* Marginal zone lymphomas include MALT lymphoma, nodal marginal zone lymphoma and splenic marginal zone lymphoma

Questions about survival

Talk to your doctor about your prognosis. A prognosis depends on many factors, including:

  • your health history
  • the type of cancer
  • the stage of the cancer
  • certain aspects of the cancer, such as LDH level
  • the treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Expert review and references

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2024 Canadian Cancer Society